output stringlengths 5 24.3k | instruction stringlengths 33 308 | system stringclasses 1 value |
|---|---|---|
1. Acrylic Resins [administration & dosage]; 2. Adenine [administration & dosage, analogs & derivatives]; 3. Administration, Intravaginal; 4. Agaricales [chemistry]; 5. Anti-HIV Agents [administration & dosage, adverse effects]; 6. Anti-Infective Agents, Local [*administration & dosage]; 7. Bias; 8. Cellulose [administration & dosage, adverse effects, analogs & derivatives]; 9. HIV Infections [prevention & control]; 10. Naphthalenesulfonates [administration & dosage]; 11. Placebos [administration & dosage]; 12. Polymers [administration & dosage]; 13. Pyrimidines [administration & dosage, adverse effects]; 14. Seaweed [chemistry]; 15. Sexually Transmitted Diseases [*prevention & control]; 16. Tenofovir [administration & dosage, adverse effects]; | Provide MESH terms for the study
Topical microbicides for preventing sexually transmitted infections | You are a research assistant. Based on the question please provide appropriate answers |
1. Administration, Topical; 2. Anti-Bacterial Agents [*administration & dosage, adverse effects]; 3. Antibiotic Prophylaxis [adverse effects, *methods]; 4. Bias; 5. Critical Care; 6. Cross Infection [mortality, prevention & control]; 7. Hospital Mortality; 8. Pneumonia, Ventilator-Associated [mortality, *prevention & control]; 9. Randomized Controlled Trials as Topic; 10. Respiration, Artificial [*adverse effects]; 11. Respiratory Tract Infections [mortality, *prevention & control]; | Provide MESH terms for the study
Topical antibiotic prophylaxis to reduce respiratory tract infections and mortality in adults receiving mechanical ventilation | You are a research assistant. Based on the question please provide appropriate answers |
1. Anti-Infective Agents [*administration & dosage, adverse effects]; 2. *Betacoronavirus; 3. Coronavirus Infections [prevention & control, *transmission]; 4. COVID-19; 5. *Health Personnel; 6. Infectious Disease Transmission, Patient-to-Professional [*prevention & control]; 7. Mouth [virology]; 8. Mouthwashes [*administration & dosage, adverse effects]; 9. *Nasal Sprays; 10. Nose [virology]; 11. Occupational Diseases [etiology, prevention & control]; 12. Pandemics [prevention & control]; 13. Pneumonia, Viral [prevention & control, *transmission]; 14. SARS-CoV-2; 15. Therapeutic Irrigation; | Provide MESH terms for the study
Use of antimicrobial mouthwashes (gargling) and nasal sprays by healthcare workers to protect them when treating patients with suspected or confirmed COVID‐19 infection | You are a research assistant. Based on the question please provide appropriate answers |
1. Anti-Infective Agents [*administration & dosage, adverse effects]; 2. *Betacoronavirus; 3. Coronavirus Infections [prevention & control, *therapy, transmission]; 4. COVID-19; 5. *Health Personnel; 6. Infectious Disease Transmission, Patient-to-Professional [*prevention & control]; 7. Mouth [virology]; 8. Mouthwashes [*administration & dosage, adverse effects]; 9. *Nasal Sprays; 10. Nose [virology]; 11. Occupational Diseases [etiology, prevention & control]; 12. Pandemics [prevention & control]; 13. Pneumonia, Viral [prevention & control, *therapy, transmission]; 14. SARS-CoV-2; 15. Therapeutic Irrigation; | Provide MESH terms for the study
Antimicrobial mouthwashes (gargling) and nasal sprays administered to patients with suspected or confirmed COVID‐19 infection to improve patient outcomes and to protect healthcare workers treating them | You are a research assistant. Based on the question please provide appropriate answers |
1. *Betacoronavirus; 2. *Coronavirus Infections [epidemiology]; 3. COVID-19; 4. Depression [diagnosis]; 5. Homes for the Aged; 6. Loneliness [*psychology]; 7. Nursing Homes; 8. *Online Social Networking; 9. *Pandemics; 10. *Pneumonia, Viral [epidemiology]; 11. Quality of Life; 12. Randomized Controlled Trials as Topic; 13. SARS-CoV-2; 14. Social Control, Informal [methods]; 15. Social Isolation [*psychology]; | Provide MESH terms for the study
Video calls for reducing social isolation and loneliness in older people: a rapid review | You are a research assistant. Based on the question please provide appropriate answers |
1. Antitubercular Agents [*therapeutic use]; 2. Clinical Protocols; 3. Drug Administration Schedule; 4. Drug Combinations; 5. Drug Therapy, Combination [methods]; 6. Randomized Controlled Trials as Topic; 7. Tuberculosis, Pulmonary [*drug therapy]; | Provide MESH terms for the study
Shortened treatment regimens versus the standard regimen for drug‐sensitive pulmonary tuberculosis | You are a research assistant. Based on the question please provide appropriate answers |
1. Anti‐Bacterial Agents [*therapeutic use]; 2. Asymptomatic Infections; 3. Bacteriuria [complications, *drug therapy]; 4. Infant, Low Birth Weight; 5. Pregnancy Complications, Infectious [*drug therapy]; 6. Pregnancy Outcome; 7. Premature Birth [prevention & control]; 8. Pyelonephritis [prevention & control]; 9. Randomized Controlled Trials as Topic; | Provide MESH terms for the study
Antibiotics for asymptomatic bacteriuria in pregnancy | You are a research assistant. Based on the question please provide appropriate answers |
1. Anti‐Bacterial Agents [therapeutic use]; 2. Drainage; 3. Empyema, Pleural [*therapy]; 4. Fibrinolytic Agents [*therapeutic use]; 5. Pleural Effusion [*therapy]; 6. Randomized Controlled Trials as Topic; 7. Streptokinase [therapeutic use]; 8. Thrombolytic Therapy [*methods]; 9. Tissue Plasminogen Activator [therapeutic use]; 10. Urokinase‐Type Plasminogen Activator [therapeutic use]; | Provide MESH terms for the study
Intra‐pleural fibrinolytic therapy versus placebo, or a different fibrinolytic agent, in the treatment of adult parapneumonic effusions and empyema | You are a research assistant. Based on the question please provide appropriate answers |
1. Anti-Retroviral Agents [adverse effects, *therapeutic use]; 2. Developing Countries; 3. HIV Infections [*drug therapy, mortality]; 4. Medication Adherence [statistics & numerical data]; 5. Pregnancy Complications, Infectious [drug therapy]; 6. Randomized Controlled Trials as Topic [statistics & numerical data]; 7. Time Factors; 8. *Time-to-Treatment; | Provide MESH terms for the study
Rapid initiation of antiretroviral therapy for people living with HIV | You are a research assistant. Based on the question please provide appropriate answers |
1. *Community Health Services; 2. Anti‐Bacterial Agents [*therapeutic use]; 3. Bacterial Infections [*drug therapy]; 4. Developing Countries; 5. Infant Mortality; 6. Randomized Controlled Trials as Topic; | Provide MESH terms for the study
Community‐based antibiotic delivery for possible serious bacterial infections in neonates in low‐ and middle‐income countries | You are a research assistant. Based on the question please provide appropriate answers |
1. AIDS-Related Opportunistic Infections [prevention & control]; 2. Antifungal Agents [adverse effects, *therapeutic use]; 3. Candida [drug effects]; 4. Cause of Death; 5. CD4 Lymphocyte Count; 6. Cryptococcosis [mortality, *prevention & control]; 7. Drug Resistance, Fungal; 8. Fluconazole [adverse effects, *therapeutic use]; 9. HIV Seropositivity [*complications, immunology]; 10. Itraconazole [adverse effects, *therapeutic use]; 11. *Primary Prevention; 12. Randomized Controlled Trials as Topic; | Provide MESH terms for the study
Primary antifungal prophylaxis for cryptococcal disease in HIV‐positive people | You are a research assistant. Based on the question please provide appropriate answers |
1. AIDS-Related Opportunistic Infections [drug therapy]; 2. Amphotericin B [administration & dosage, adverse effects]; 3. Anti-HIV Agents [*administration & dosage]; 4. Antifungal Agents [*administration & dosage, adverse effects]; 5. Cause of Death; 6. Drug Administration Schedule; 7. Fluconazole [administration & dosage, adverse effects]; 8. HIV Infections [complications, *drug therapy, mortality]; 9. Meningitis, Cryptococcal [complications, *drug therapy]; 10. Randomized Controlled Trials as Topic; | Provide MESH terms for the study
Early versus delayed antiretroviral treatment in HIV‐positive people with cryptococcal meningitis | You are a research assistant. Based on the question please provide appropriate answers |
1. Disease Progression; 2. Influenza Vaccines [adverse effects, *therapeutic use]; 3. Influenza, Human [*prevention & control]; 4. Lung Diseases, Obstructive [*complications]; 5. Randomized Controlled Trials as Topic; 6. Vaccines, Attenuated [adverse effects, therapeutic use]; 7. Vaccines, Inactivated [adverse effects, therapeutic use]; | Provide MESH terms for the study
Influenza vaccine for chronic obstructive pulmonary disease (COPD) | You are a research assistant. Based on the question please provide appropriate answers |
1. Amoxicillin‐Potassium Clavulanate Combination; 2. Anti‐Bacterial Agents [therapeutic use]; 3. CD28 Antigens [therapeutic use]; 4. Critical Care; 5. Debridement; 6. Fluoroquinolones [therapeutic use]; 7. Immunoglobulins, Intravenous [therapeutic use]; 8. Moxifloxacin; 9. Randomized Controlled Trials as Topic; 10. Soft Tissue Infections [complications, *therapy]; | Provide MESH terms for the study
Interventions for necrotizing soft tissue infections in adults | You are a research assistant. Based on the question please provide appropriate answers |
1. *Reminder Systems; 2. Attitude of Health Personnel; 3. Community Participation; 4. Health Services Needs and Demand; 5. Immunization Programs [*methods]; 6. Influenza Vaccines [*administration & dosage]; 7. Influenza, Human [*prevention & control]; 8. Randomized Controlled Trials as Topic; 9. Vaccination [*statistics & numerical data]; | Provide MESH terms for the study
Interventions to increase influenza vaccination rates of those 60 years and older in the community | You are a research assistant. Based on the question please provide appropriate answers |
1. Adrenal Cortex Hormones [therapeutic use]; 2. Anti‐Bacterial Agents [therapeutic use]; 3. Combined Modality Therapy [methods]; 4. Community‐Acquired Infections [complications, metabolism, mortality, therapy]; 5. Deafness [epidemiology, prevention & control]; 6. Dexamethasone [therapeutic use]; 7. Diuretics, Osmotic [adverse effects, *therapeutic use]; 8. Epilepsy [prevention & control]; 9. Gastrointestinal Hemorrhage [prevention & control]; 10. Glucose [therapeutic use]; 11. Glycerol [adverse effects, *therapeutic use]; 12. Intracranial Pressure [physiology]; 13. Meningitis, Bacterial [complications, metabolism, mortality, *therapy]; 14. Nervous System Diseases [epidemiology, prevention & control]; 15. Osmosis [physiology]; 16. Osmotic Pressure [physiology]; 17. Randomized Controlled Trials as Topic; | Provide MESH terms for the study
Osmotic therapies added to antibiotics for acute bacterial meningitis | You are a research assistant. Based on the question please provide appropriate answers |
1. Antidepressive Agents [adverse effects, *therapeutic use]; 2. Confidence Intervals; 3. Depression [drug therapy]; 4. HIV Infections [*psychology]; 5. Patient Dropouts [statistics & numerical data]; 6. Placebos [therapeutic use]; 7. Quality of Life; 8. Randomized Controlled Trials as Topic; 9. Risk; 10. Selective Serotonin Reuptake Inhibitors [adverse effects, therapeutic use]; | Provide MESH terms for the study
Antidepressants for depression in adults with HIV infection | You are a research assistant. Based on the question please provide appropriate answers |
1. Adrenal Cortex Hormones [adverse effects, *therapeutic use]; 2. Ampicillin [adverse effects, therapeutic use]; 3. Anti‐Bacterial Agents [therapeutic use]; 4. Budesonide [adverse effects, therapeutic use]; 5. Dexamethasone [adverse effects, therapeutic use]; 6. Hydrocortisone [adverse effects, therapeutic use]; 7. Pneumonia [*drug therapy, mortality]; 8. Prednisolone [adverse effects, therapeutic use]; 9. Randomized Controlled Trials as Topic; | Provide MESH terms for the study
Corticosteroids for pneumonia | You are a research assistant. Based on the question please provide appropriate answers |
1. *Haemophilus ducreyi; 2. Anti‐Bacterial Agents [*therapeutic use]; 3. Azithromycin [therapeutic use]; 4. Chancroid [*drug therapy]; 5. Erythromycin [adverse effects, therapeutic use]; 6. Leucomycins [therapeutic use]; 7. Macrolides [adverse effects, *therapeutic use]; 8. Randomized Controlled Trials as Topic; 9. Treatment Outcome; | Provide MESH terms for the study
Macrolides for treatment of Haemophilus ducreyi infection in sexually active adults | You are a research assistant. Based on the question please provide appropriate answers |
1. *Community Health Services; 2. *Patient Acceptance of Health Care; 3. *Primary Health Care; 4. Early Diagnosis; 5. Non‐Randomized Controlled Trials as Topic; 6. Prevalence; 7. Program Evaluation; 8. Randomized Controlled Trials as Topic; 9. Tuberculosis, Pulmonary [*diagnosis, drug therapy, mortality]; | Provide MESH terms for the study
Interventions to increase tuberculosis case detection at primary healthcare or community‐level services | You are a research assistant. Based on the question please provide appropriate answers |
1. Amoxicillin [administration & dosage]; 2. Anti-Bacterial Agents [administration & dosage]; 3. *Antibiotic Prophylaxis; 4. Chloramphenicol [administration & dosage]; 5. Clavulanic Acid [administration & dosage]; 6. *Delivery, Obstetric; 7. Endometritis [epidemiology, *prevention & control]; 8. Episiotomy [adverse effects]; 9. Non-Randomized Controlled Trials as Topic; 10. Puerperal Infection [epidemiology, *prevention & control]; 11. Randomized Controlled Trials as Topic; 12. Sulfamethoxypyridazine [administration & dosage]; 13. Surgical Wound Infection [epidemiology, prevention & control]; 14. Urinary Tract Infections [epidemiology, prevention & control]; | Provide MESH terms for the study
Routine antibiotic prophylaxis after normal vaginal birth for reducing maternal infectious morbidity | You are a research assistant. Based on the question please provide appropriate answers |
1. Acute Disease; 2. Anti‐Bacterial Agents [adverse effects, *therapeutic use]; 3. Bacterial Infections [blood, *drug therapy, mortality]; 4. Biomarkers [blood]; 5. Calcitonin [*blood]; 6. Calcitonin Gene‐Related Peptide; 7. Cause of Death; 8. Protein Precursors [*blood]; 9. Randomized Controlled Trials as Topic; 10. Respiratory Tract Infections [blood, *drug therapy, mortality]; 11. Treatment Failure; | Provide MESH terms for the study
Procalcitonin to initiate or discontinue antibiotics in acute respiratory tract infections | You are a research assistant. Based on the question please provide appropriate answers |
1. Anti‐Bacterial Agents [*administration & dosage]; 2. Community‐Acquired Infections [drug therapy]; 3. Drug Administration Schedule; 4. Injections, Intravenous; 5. Pneumonia [*drug therapy]; 6. Time Factors; | Provide MESH terms for the study
Short‐course versus long‐course intravenous therapy with the same antibiotic for severe community‐acquired pneumonia in children aged two months to 59 months | You are a research assistant. Based on the question please provide appropriate answers |
1. Bias; 2. Disability Evaluation; 3. Encephalitis, Japanese [therapy]; 4. Encephalitis, Viral [*therapy]; 5. Glasgow Coma Scale; 6. Immunoglobulins, Intravenous [adverse effects, *therapeutic use]; 7. Length of Stay; 8. Placebos [therapeutic use]; 9. Randomized Controlled Trials as Topic; | Provide MESH terms for the study
Intravenous immunoglobulin for the treatment of childhood encephalitis | You are a research assistant. Based on the question please provide appropriate answers |
1. *Escherichia coli; 2. Probiotics [adverse effects, *therapeutic use]; 3. Randomized Controlled Trials as Topic; 4. Urinary Bladder, Neurogenic [*complications]; 5. Urinary Tract Infections [*prevention & control]; | Provide MESH terms for the study
Probiotics for preventing urinary tract infection in people with neuropathic bladder | You are a research assistant. Based on the question please provide appropriate answers |
1. AIDS-Related Opportunistic Infections [mortality, *prevention & control]; 2. Anti-HIV Agents [therapeutic use]; 3. Antitubercular Agents [adverse effects, *therapeutic use]; 4. HIV Infections [drug therapy, *mortality]; 5. Incidence; 6. Isoniazid [adverse effects, *therapeutic use]; 7. Randomized Controlled Trials as Topic; 8. Trimethoprim, Sulfamethoxazole Drug Combination [adverse effects, therapeutic use]; 9. Tuberculosis, Multidrug-Resistant [epidemiology]; 10. Tuberculosis, Pulmonary [drug therapy, *mortality, *prevention & control]; | Provide MESH terms for the study
Isoniazid for preventing tuberculosis in HIV‐infected children | You are a research assistant. Based on the question please provide appropriate answers |
1. Acute Disease; 2. Anti‐Bacterial Agents [*therapeutic use]; 3. Bronchiolitis [*complications, virology]; 4. Clarithromycin [*therapeutic use]; 5. Cough [*drug therapy, etiology]; 6. Randomized Controlled Trials as Topic; 7. Respiratory Sounds [*drug effects, etiology]; 8. Respiratory Syncytial Virus Infections [complications, *drug therapy]; | Provide MESH terms for the study
Antibiotics for persistent cough or wheeze following acute bronchiolitis in children | You are a research assistant. Based on the question please provide appropriate answers |
1. Fever [therapy]; 2. Measles [complications, mortality, *therapy]; 3. Pneumonia [therapy]; 4. Randomized Controlled Trials as Topic; 5. Zinc [*administration & dosage, deficiency]; | Provide MESH terms for the study
Zinc supplementation for the treatment of measles in children | You are a research assistant. Based on the question please provide appropriate answers |
1. Administration, Oral; 2. Anti‐Bacterial Agents [administration & dosage]; 3. Bronchitis, Chronic [mortality, *prevention & control]; 4. Disease Progression; 5. Haemophilus Vaccines [*administration & dosage]; 6. Haemophilus influenzae [*immunology]; 7. Pulmonary Disease, Chronic Obstructive [mortality, *prevention & control]; 8. Randomized Controlled Trials as Topic; 9. Secondary Prevention; 10. Tablets, Enteric‐Coated; | Provide MESH terms for the study
Haemophilus influenzae oral vaccination for preventing acute exacerbations of chronic bronchitis and chronic obstructive pulmonary disease | You are a research assistant. Based on the question please provide appropriate answers |
1. Acute Disease; 2. Anti‐Bacterial Agents [*therapeutic use]; 3. Bronchitis [*drug therapy]; 4. Cough [drug therapy]; 5. Randomized Controlled Trials as Topic; | Provide MESH terms for the study
Antibiotics for acute bronchitis | You are a research assistant. Based on the question please provide appropriate answers |
1. *Antibiotic Prophylaxis; 2. Anti‐Bacterial Agents [therapeutic use]; 3. Ceftriaxone [therapeutic use]; 4. Chloramphenicol [therapeutic use]; 5. Injections, Intramuscular; 6. Meningitis, Meningococcal [complications, drug therapy, mortality]; 7. Meningococcal Infections [complications, *drug therapy, mortality]; 8. Patient Admission; | Provide MESH terms for the study
Pre‐admission antibiotics for suspected cases of meningococcal disease | You are a research assistant. Based on the question please provide appropriate answers |
1. *Cardiac Surgical Procedures; 2. Anti‐Bacterial Agents [*therapeutic use]; 3. Anti‐Infective Agents, Local [*therapeutic use]; 4. Carrier State [*drug therapy]; 5. Chlorhexidine [therapeutic use]; 6. Drug Combinations; 7. Iodine [therapeutic use]; 8. Mupirocin [therapeutic use]; 9. Nose [*microbiology]; 10. Randomized Controlled Trials as Topic; 11. Staphylococcal Infections [*drug therapy, mortality]; 12. Staphylococcus aureus; 13. Surgical Wound Infection [*prevention & control]; | Provide MESH terms for the study
Nasal decontamination for the prevention of surgical site infection in Staphylococcus aureus carriers | You are a research assistant. Based on the question please provide appropriate answers |
1. *Thoracic Surgery, Video‐Assisted [adverse effects, mortality]; 2. *Thoracostomy [adverse effects, mortality]; 3. Drainage [adverse effects, methods, mortality]; 4. Empyema, Pleural [mortality, surgery, *therapy]; 5. Length of Stay; 6. Randomized Controlled Trials as Topic; 7. Selection Bias; 8. Thrombolytic Therapy; | Provide MESH terms for the study
Surgical versus non‐surgical management for pleural empyema | You are a research assistant. Based on the question please provide appropriate answers |
1. Anti‐Bacterial Agents [therapeutic use]; 2. Biomarkers [blood]; 3. Calcitonin [*blood]; 4. Intensive Care Units; 5. Patient Discharge; 6. Randomized Controlled Trials as Topic; 7. Sepsis [*blood, drug therapy, *mortality]; 8. Shock, Septic [blood, drug therapy, mortality]; 9. Time Factors; | Provide MESH terms for the study
Effectiveness and safety of procalcitonin evaluation for reducing mortality in adults with sepsis, severe sepsis or septic shock | You are a research assistant. Based on the question please provide appropriate answers |
1. *Bandages; 2. Alginates [administration & dosage]; 3. Bandages, Hydrocolloid; 4. Biguanides; 5. Disinfectants; 6. Randomized Controlled Trials as Topic; 7. Silver [administration & dosage]; 8. Surgical Wound Infection [classification, *prevention & control]; 9. Wound Healing; | Provide MESH terms for the study
Dressings for the prevention of surgical site infection | You are a research assistant. Based on the question please provide appropriate answers |
1. Acute Disease; 2. Acyclovir [adverse effects, *analogs & derivatives, *therapeutic use]; 3. Antiviral Agents [adverse effects, *therapeutic use]; 4. Guanine [adverse effects, *analogs & derivatives, therapeutic use]; 5. Infectious Mononucleosis [*drug therapy]; 6. Randomized Controlled Trials as Topic; 7. Valacyclovir; 8. Valine [adverse effects, *analogs & derivatives, therapeutic use]; | Provide MESH terms for the study
Antiviral agents for infectious mononucleosis (glandular fever) | You are a research assistant. Based on the question please provide appropriate answers |
1. Anti‐Bacterial Agents [*administration & dosage, adverse effects, pharmacokinetics]; 2. Drug Administration Schedule; 3. Gentamicins [*administration & dosage, adverse effects, pharmacokinetics]; 4. Hearing [drug effects]; 5. Kidney [drug effects]; 6. Randomized Controlled Trials as Topic; 7. Sepsis [*drug therapy, metabolism]; | Provide MESH terms for the study
One dose per day compared to multiple doses per day of gentamicin for treatment of suspected or proven sepsis in neonates | You are a research assistant. Based on the question please provide appropriate answers |
1. *Contraception; 2. Herpes Genitalis [epidemiology, *prevention & control, transmission]; 3. Herpesvirus 2, Human; 4. HIV Infections [epidemiology, *prevention & control, transmission]; 5. *Pregnancy in Adolescence; 6. Program Evaluation; 7. Randomized Controlled Trials as Topic; 8. Reward; 9. *School Health Services; 10. Sex Education; 11. Sexually Transmitted Diseases [prevention & control]; 12. Syphilis [epidemiology, *prevention & control]; | Provide MESH terms for the study
School‐based interventions for preventing HIV, sexually transmitted infections, and pregnancy in adolescents | You are a research assistant. Based on the question please provide appropriate answers |
1. *Wound Healing; 2. Administration, Topical; 3. Anti‐Bacterial Agents; 4. Anti‐Infective Agents, Local [*administration & dosage, adverse effects]; 5. Dermatitis, Allergic Contact [etiology]; 6. Drug Resistance, Bacterial; 7. Randomized Controlled Trials as Topic; 8. Surgical Wound Infection [*prevention & control]; | Provide MESH terms for the study
Topical antibiotics for preventing surgical site infection in wounds healing by primary intention | You are a research assistant. Based on the question please provide appropriate answers |
1. Acute Disease; 2. Developing Countries; 3. Fluid Therapy [adverse effects, methods, *standards]; 4. Hyponatremia [etiology]; 5. Meningitis, Bacterial [complications, *therapy]; 6. Randomized Controlled Trials as Topic; | Provide MESH terms for the study
Fluid therapy for acute bacterial meningitis | You are a research assistant. Based on the question please provide appropriate answers |
1. Anti‐Bacterial Agents [adverse effects, *therapeutic use]; 2. Carbapenems [therapeutic use]; 3. Cause of Death; 4. Drug Therapy, Combination [mortality]; 5. Empirical Research; 6. Pneumonia, Ventilator‐Associated [*drug therapy, mortality]; 7. Randomized Controlled Trials as Topic; | Provide MESH terms for the study
Antibiotics for ventilator‐associated pneumonia | You are a research assistant. Based on the question please provide appropriate answers |
1. *Sexual Behavior; 2. HIV Infections [*prevention & control]; 3. Mental Disorders [*complications]; | Provide MESH terms for the study
HIV prevention advice for people with serious mental illness | You are a research assistant. Based on the question please provide appropriate answers |
1. Acyclovir [adverse effects, analogs & derivatives, therapeutic use]; 2. Administration, Oral; 3. Antiviral Agents [adverse effects, therapeutic use]; 4. Herpes Genitalis [*drug therapy]; 5. Injections, Intravenous; 6. Randomized Controlled Trials as Topic; 7. Recurrence; 8. Valacyclovir; 9. Valine [adverse effects, analogs & derivatives, therapeutic use]; | Provide MESH terms for the study
Interventions for men and women with their first episode of genital herpes | You are a research assistant. Based on the question please provide appropriate answers |
1. *Exercise; 2. *Vaccination; 3. Incidence; 4. Influenza Vaccines [*administration & dosage, adverse effects]; 5. Influenza, Human [complications, epidemiology, *prevention & control]; 6. Randomized Controlled Trials as Topic; 7. Resistance Training [methods]; 8. Time Factors; 9. Walking; | Provide MESH terms for the study
Exercise prior to influenza vaccination for limiting influenza incidence and its related complications in adults | You are a research assistant. Based on the question please provide appropriate answers |
1. *Contraception Behavior; 2. *HIV Seronegativity; 3. *HIV Seropositivity; 4. Condoms [statistics & numerical data]; 5. Contraceptive Agents, Female [*administration & dosage]; 6. Family Planning Services; 7. Pregnancy Rate; | Provide MESH terms for the study
Behavioral interventions for improving contraceptive use among women living with HIV | You are a research assistant. Based on the question please provide appropriate answers |
1. Glucocorticoids [administration & dosage, adverse effects, *therapeutic use]; 2. Leprosy [*complications]; 3. Methylprednisolone [therapeutic use]; 4. Peripheral Nervous System Diseases [diagnosis, *drug therapy, etiology]; 5. Prednisolone [administration & dosage, therapeutic use]; 6. Randomized Controlled Trials as Topic; 7. Somatosensory Disorders [diagnosis, *drug therapy, etiology]; | Provide MESH terms for the study
Corticosteroids for treating nerve damage in leprosy | You are a research assistant. Based on the question please provide appropriate answers |
1. *Primary Prevention; 2. *Secondary Prevention; 3. Anticonvulsants [*therapeutic use]; 4. Encephalitis, Viral [*complications]; 5. Seizures [etiology, *prevention & control]; | Provide MESH terms for the study
Antiepileptic drugs for the primary and secondary prevention of seizures in viral encephalitis | You are a research assistant. Based on the question please provide appropriate answers |
1. Antitubercular Agents [*administration & dosage]; 2. Drug Combinations; 3. Drug Therapy, Combination [methods]; 4. Medication Adherence; 5. Randomized Controlled Trials as Topic; 6. Tuberculosis, Pulmonary [*drug therapy]; | Provide MESH terms for the study
Fixed‐dose combinations of drugs versus single‐drug formulations for treating pulmonary tuberculosis | You are a research assistant. Based on the question please provide appropriate answers |
1. Antifungal Agents [*therapeutic use]; 2. Fluconazole [therapeutic use]; 3. Griseofulvin [therapeutic use]; 4. Itraconazole [therapeutic use]; 5. Ketoconazole [therapeutic use]; 6. Naphthalenes [therapeutic use]; 7. Randomized Controlled Trials as Topic; 8. Terbinafine; 9. Tinea Capitis [*drug therapy]; | Provide MESH terms for the study
Systemic antifungal therapy for tinea capitis in children | You are a research assistant. Based on the question please provide appropriate answers |
1. Antitubercular Agents [*therapeutic use]; 2. Chemotherapy, Adjuvant; 3. Dexamethasone [therapeutic use]; 4. Glucocorticoids [*therapeutic use]; 5. Hydrocortisone [therapeutic use]; 6. Intention to Treat Analysis; 7. Prednisolone [therapeutic use]; 8. Randomized Controlled Trials as Topic; 9. Tuberculosis, Meningeal [*drug therapy, mortality]; | Provide MESH terms for the study
Corticosteroids for managing tuberculous meningitis | You are a research assistant. Based on the question please provide appropriate answers |
1. *Bacteremia; 2. *Watchful Waiting; 3. Catheter‐Related Infections [*blood, prevention & control]; 4. Catheterization, Central Venous [*instrumentation]; 5. Catheters, Indwelling [*adverse effects]; 6. Device Removal [*standards]; 7. Time Factors; | Provide MESH terms for the study
Early removal versus expectant management of central venous catheters in neonates with bloodstream infection | You are a research assistant. Based on the question please provide appropriate answers |
1. Antacids [*urine]; 2. Anti‐Infective Agents, Urinary [therapeutic use]; 3. Hydrogen‐Ion Concentration [drug effects]; 4. Urinary Tract Infections [*drug therapy, urine]; 5. Urine [chemistry]; | Provide MESH terms for the study
Urinary alkalisation for symptomatic uncomplicated urinary tract infection in women | You are a research assistant. Based on the question please provide appropriate answers |
1. *Endemic Diseases; 2. Anthelmintics [*therapeutic use]; 3. CD4 Lymphocyte Count; 4. Disease Progression; 5. HIV Infections [immunology, *parasitology, virology]; 6. HIV‐1 [*genetics]; 7. Health Resources; 8. Helminthiasis [complications, *drug therapy]; 9. Poverty Areas; 10. RNA, Viral [analysis]; 11. Randomized Controlled Trials as Topic; 12. Viral Load; | Provide MESH terms for the study
Antihelminthics in helminth‐endemic areas: effects on HIV disease progression | You are a research assistant. Based on the question please provide appropriate answers |
1. *Infant, Low Birth Weight; 2. *Infant, Premature; 3. Administration, Oral; 4. Enterocolitis, Necrotizing [*prevention & control]; 5. Immunoglobulin A [*administration & dosage]; 6. Immunoglobulin G [*administration & dosage]; 7. Infant, Premature, Diseases [*prevention & control]; 8. Randomized Controlled Trials as Topic; | Provide MESH terms for the study
Oral immunoglobulin for preventing necrotizing enterocolitis in preterm and low birth weight neonates | You are a research assistant. Based on the question please provide appropriate answers |
1. Acute Disease; 2. Amoxicillin‐Potassium Clavulanate Combination [*therapeutic use]; 3. Ampicillin [*therapeutic use]; 4. Anti‐Bacterial Agents [*therapeutic use]; 5. Otitis [*prevention & control]; 6. Pneumonia [*prevention & control]; 7. Randomized Controlled Trials as Topic; 8. Respiratory Tract Infections [complications, drug therapy]; 9. Suppuration [drug therapy]; | Provide MESH terms for the study
Antibiotics for preventing suppurative complications from undifferentiated acute respiratory infections in children under five years of age | You are a research assistant. Based on the question please provide appropriate answers |
1. Anti‐Inflammatory Agents [adverse effects, *therapeutic use]; 2. Anticoagulants [adverse effects, *therapeutic use]; 3. Antithrombin III [adverse effects, *therapeutic use]; 4. Critical Illness [*mortality]; 5. Randomized Controlled Trials as Topic; | Provide MESH terms for the study
Antithrombin III for critically ill patients | You are a research assistant. Based on the question please provide appropriate answers |
1. Bandages [*statistics & numerical data]; 2. Catheter‐Related Infections [*epidemiology, mortality]; 3. Cause of Death; 4. Central Venous Catheters [*adverse effects]; 5. Incidence; 6. Pain Measurement; 7. Randomized Controlled Trials as Topic; 8. Skin [injuries]; 9. Surgical Tape [adverse effects]; 10. Time Factors; | Provide MESH terms for the study
Frequency of dressing changes for central venous access devices on catheter‐related infections | You are a research assistant. Based on the question please provide appropriate answers |
1. *Strongyloides stercoralis; 2. Albendazole [adverse effects, *therapeutic use]; 3. Anthelmintics [adverse effects, *therapeutic use]; 4. Ivermectin [adverse effects, *therapeutic use]; 5. Randomized Controlled Trials as Topic; 6. Strongyloidiasis [*drug therapy]; 7. Thiabendazole [adverse effects, *therapeutic use]; | Provide MESH terms for the study
Ivermectin versus albendazole or thiabendazole for Strongyloides stercoralis infection | You are a research assistant. Based on the question please provide appropriate answers |
1. Amphotericin B [therapeutic use]; 2. Antifungal Agents [*therapeutic use]; 3. Critical Illness [*mortality]; 4. Fluconazole [therapeutic use]; 5. Immunocompromised Host; 6. Mycoses [mortality, *prevention & control]; 7. Randomized Controlled Trials as Topic; | Provide MESH terms for the study
Antifungal agents for preventing fungal infections in non‐neutropenic critically ill patients | You are a research assistant. Based on the question please provide appropriate answers |
1. *Respiration, Artificial [statistics & numerical data]; 2. Anti‐Bacterial Agents [therapeutic use]; 3. Hospital Mortality; 4. Intensive Care Units [statistics & numerical data]; 5. Length of Stay; 6. Patient Positioning [*methods]; 7. Pneumonia, Ventilator‐Associated [microbiology, mortality, *prevention & control]; 8. Pressure Ulcer [epidemiology]; 9. Randomized Controlled Trials as Topic; 10. Supine Position; | Provide MESH terms for the study
Semi‐recumbent position versus supine position for the prevention of ventilator‐associated pneumonia in adults requiring mechanical ventilation | You are a research assistant. Based on the question please provide appropriate answers |
1. Anti‐Bacterial Agents [adverse effects, *therapeutic use]; 2. Drug Eruptions [etiology]; 3. Length of Stay; 4. Linezolid [adverse effects, *therapeutic use]; 5. Pruritus [chemically induced]; 6. Randomized Controlled Trials as Topic; 7. Skin Diseases, Bacterial [*drug therapy]; 8. Soft Tissue Infections [*drug therapy]; 9. Thrombocytopenia [chemically induced]; 10. Vancomycin [adverse effects, *therapeutic use]; | Provide MESH terms for the study
Linezolid versus vancomycin for skin and soft tissue infections | You are a research assistant. Based on the question please provide appropriate answers |
1. Anti‐Bacterial Agents [therapeutic use]; 2. Cause of Death; 3. Chemotherapy, Adjuvant [methods]; 4. Dexamethasone [*therapeutic use]; 5. Glucocorticoids [*therapeutic use]; 6. Hearing Loss, Sensorineural [etiology]; 7. Meningitis, Bacterial [complications, *drug therapy, mortality]; 8. Randomized Controlled Trials as Topic; | Provide MESH terms for the study
Adjuvant corticosteroids for reducing death in neonatal bacterial meningitis | You are a research assistant. Based on the question please provide appropriate answers |
1. *Asymptomatic Infections; 2. Anti‐Bacterial Agents [*administration & dosage, therapeutic use]; 3. Bacteriuria [*drug therapy]; 4. Drug Administration Schedule; 5. Pregnancy Complications, Infectious [*drug therapy]; 6. Randomized Controlled Trials as Topic; | Provide MESH terms for the study
Duration of treatment for asymptomatic bacteriuria during pregnancy | You are a research assistant. Based on the question please provide appropriate answers |
1. Adrenal Cortex Hormones [*therapeutic use]; 2. Infectious Mononucleosis [*drug therapy]; 3. Randomized Controlled Trials as Topic; | Provide MESH terms for the study
Steroids for symptom control in infectious mononucleosis | You are a research assistant. Based on the question please provide appropriate answers |
1. *Infant, Very Low Birth Weight; 2. Administration, Oral; 3. Administration, Topical; 4. Antifungal Agents [*therapeutic use]; 5. Fluconazole [therapeutic use]; 6. Infant, Premature; 7. Infant, Premature, Diseases [*prevention & control]; 8. Miconazole [therapeutic use]; 9. Mycoses [*prevention & control]; 10. Nystatin [therapeutic use]; 11. Randomized Controlled Trials as Topic; | Provide MESH terms for the study
Prophylactic oral/topical non‐absorbed antifungal agents to prevent invasive fungal infection in very low birth weight infants | You are a research assistant. Based on the question please provide appropriate answers |
1. *Infant, Very Low Birth Weight; 2. Antifungal Agents [*therapeutic use]; 3. Developmental Disabilities [etiology, *prevention & control]; 4. Fluconazole [therapeutic use]; 5. Infant, Premature, Diseases [mortality, *prevention & control]; 6. Mycoses [complications, mortality, *prevention & control]; 7. Randomized Controlled Trials as Topic; | Provide MESH terms for the study
Prophylactic systemic antifungal agents to prevent mortality and morbidity in very low birth weight infants | You are a research assistant. Based on the question please provide appropriate answers |
1. Hygiene [*education]; 2. Pregnancy Complications, Parasitic [*prevention & control]; 3. Prenatal Care [*methods]; 4. Randomized Controlled Trials as Topic; 5. Rare Diseases [parasitology, *prevention & control]; 6. Toxoplasmosis, Congenital [*prevention & control]; | Provide MESH terms for the study
Prenatal education for congenital toxoplasmosis | You are a research assistant. Based on the question please provide appropriate answers |
1. Anemia, Sickle Cell [complications]; 2. Anti-Bacterial Agents [*therapeutic use]; 3. Cystic Fibrosis [complications]; 4. HIV Infections [complications]; 5. Randomized Controlled Trials as Topic; 6. Respiratory Tract Infections [*drug therapy]; | Provide MESH terms for the study
Antibiotics for preventing lower respiratory tract infections in high‐risk children aged 12 years and under | You are a research assistant. Based on the question please provide appropriate answers |
1. Acute Disease; 2. Administration, Inhalation; 3. Bronchiolitis, Viral [*drug therapy]; 4. Bronchodilator Agents [*administration & dosage]; 5. Helium [*administration & dosage]; 6. Intensive Care Units, Pediatric [statistics & numerical data]; 7. Intubation, Intratracheal [statistics & numerical data]; 8. Length of Stay; 9. Oxygen [*administration & dosage]; 10. Randomized Controlled Trials as Topic; 11. Respiratory Syncytial Virus Infections [*complications]; | Provide MESH terms for the study
Heliox inhalation therapy for bronchiolitis in infants | You are a research assistant. Based on the question please provide appropriate answers |
1. Acute Disease; 2. Anti‐Inflammatory Agents [adverse effects, therapeutic use]; 3. Developed Countries; 4. Developing Countries; 5. Dexamethasone [therapeutic use]; 6. Glucocorticoids [adverse effects, *therapeutic use]; 7. Hearing Loss [etiology, prevention & control]; 8. Hydrocortisone [therapeutic use]; 9. Meningitis, Bacterial [complications, *drug therapy, mortality]; 10. Prednisolone [therapeutic use]; 11. Randomized Controlled Trials as Topic; | Provide MESH terms for the study
Corticosteroids for acute bacterial meningitis | You are a research assistant. Based on the question please provide appropriate answers |
1. Infusions, Intravenous; 2. Injections, Intramuscular; 3. Post‐Exposure Prophylaxis [*methods]; 4. Prospective Studies; 5. Randomized Controlled Trials as Topic; 6. Rubella [*prevention & control]; 7. Rubella Syndrome, Congenital [*prevention & control]; 8. Sodium Chloride [administration & dosage]; 9. gamma‐Globulins [*administration & dosage]; | Provide MESH terms for the study
Post‐exposure passive immunisation for preventing rubella and congenital rubella syndrome | You are a research assistant. Based on the question please provide appropriate answers |
1. Acute Disease; 2. Adrenergic beta‐2 Receptor Agonists [*therapeutic use]; 3. Airway Obstruction [drug therapy]; 4. Bronchitis [*drug therapy]; 5. Bronchodilator Agents [therapeutic use]; 6. Cough [*drug therapy]; 7. Randomized Controlled Trials as Topic; | Provide MESH terms for the study
Beta2‐agonists for acute cough or a clinical diagnosis of acute bronchitis | You are a research assistant. Based on the question please provide appropriate answers |
1. *Motivation; 2. *Token Economy; 3. Ill‐Housed Persons; 4. Medication Adherence [psychology, statistics & numerical data]; 5. Patient Compliance [*psychology, statistics & numerical data]; 6. Prisoners; 7. Randomized Controlled Trials as Topic; 8. Substance‐Related Disorders [complications]; 9. Tuberculin Test [psychology]; 10. Tuberculosis, Pulmonary [diagnosis, drug therapy, *psychology]; | Provide MESH terms for the study
Incentives and enablers to improve adherence in tuberculosis | You are a research assistant. Based on the question please provide appropriate answers |
1. *Critical Illness; 2. Anti‐Bacterial Agents [*administration & dosage]; 3. Cross Infection [*drug therapy]; 4. Drug Administration Schedule; 5. Intensive Care Units; 6. Pneumonia [*drug therapy, microbiology]; 7. Pneumonia, Ventilator‐Associated [drug therapy, microbiology]; 8. Randomized Controlled Trials as Topic; 9. Time Factors; | Provide MESH terms for the study
Short‐course versus prolonged‐course antibiotic therapy for hospital‐acquired pneumonia in critically ill adults | You are a research assistant. Based on the question please provide appropriate answers |
1. Bronchiolitis [*drug therapy]; 2. Critical Illness; 3. Length of Stay; 4. Pulmonary Surfactants [*therapeutic use]; 5. Randomized Controlled Trials as Topic; 6. Respiration, Artificial [statistics & numerical data]; 7. Time Factors; | Provide MESH terms for the study
Surfactant therapy for bronchiolitis in critically ill infants | You are a research assistant. Based on the question please provide appropriate answers |
1. *Coated Materials, Biocompatible; 2. *Silver; 3. Critical Illness; 4. Intubation, Intratracheal [*instrumentation]; 5. Pneumonia, Ventilator‐Associated [*prevention & control]; 6. Randomized Controlled Trials as Topic; | Provide MESH terms for the study
Silver‐coated endotracheal tubes for prevention of ventilator‐associated pneumonia in critically ill patients | You are a research assistant. Based on the question please provide appropriate answers |
1. Antiviral Agents [adverse effects, *therapeutic use]; 2. Herpes Labialis [*prevention & control]; 3. Randomized Controlled Trials as Topic; 4. Recurrence; 5. Secondary Prevention [methods]; | Provide MESH terms for the study
Interventions for prevention of herpes simplex labialis (cold sores on the lips) | You are a research assistant. Based on the question please provide appropriate answers |
1. *Secondary Prevention; 2. Anti‐Infective Agents, Urinary [*therapeutic use]; 3. Bacteriuria [prevention & control]; 4. Nitrofurantoin [*therapeutic use]; 5. Pregnancy Complications, Infectious [*prevention & control]; 6. Randomized Controlled Trials as Topic; 7. Recurrence; 8. Urinary Tract Infections [*prevention & control]; 9. Watchful Waiting; | Provide MESH terms for the study
Interventions for preventing recurrent urinary tract infection during pregnancy | You are a research assistant. Based on the question please provide appropriate answers |
1. Cause of Death; 2. Diphtheria‐Tetanus Vaccine [*therapeutic use]; 3. Influenza Vaccines [administration & dosage]; 4. Randomized Controlled Trials as Topic; 5. Tetanus [mortality, *prevention & control]; 6. Tetanus Toxoid [*therapeutic use]; | Provide MESH terms for the study
Vaccines for women for preventing neonatal tetanus | You are a research assistant. Based on the question please provide appropriate answers |
1. *Antibiotic Prophylaxis; 2. Endometritis [*prevention & control]; 3. Fetal Membranes, Premature Rupture [prevention & control]; 4. Fetal Weight [drug effects]; 5. Pregnancy Outcome; 6. Pregnancy Trimester, Second; 7. Pregnancy Trimester, Third; 8. Pregnancy, High‐Risk; 9. Premature Birth [*prevention & control]; 10. Randomized Controlled Trials as Topic; 11. Vaginosis, Bacterial [complications, drug therapy]; | Provide MESH terms for the study
Antibiotic prophylaxis during the second and third trimester to reduce adverse pregnancy outcomes and morbidity | You are a research assistant. Based on the question please provide appropriate answers |
1. *Vaccination; 2. Haemophilus influenzae type b [*immunology]; 3. Influenza Vaccines [*administration & dosage, immunology]; 4. Influenza, Human [immunology, *prevention & control]; 5. Pregnancy Complications, Infectious [immunology, *prevention & control]; 6. Pregnancy Outcome; 7. Randomized Controlled Trials as Topic; 8. Vaccines, Inactivated [administration & dosage, immunology]; | Provide MESH terms for the study
Impact of Haemophilus influenzae type B (Hib) and viral influenza vaccinations in pregnancy for improving maternal, neonatal and infant health outcomes | You are a research assistant. Based on the question please provide appropriate answers |
1. Amoxicillin [therapeutic use]; 2. Anti‐Bacterial Agents [*therapeutic use]; 3. Catheter‐Related Infections [*prevention & control]; 4. Catheterization, Central Venous [*methods]; 5. Central Venous Catheters [*adverse effects]; 6. Confidence Intervals; 7. Fluconazole [therapeutic use]; 8. Gentamicins [therapeutic use]; 9. Intensive Care Units, Neonatal; 10. Randomized Controlled Trials as Topic; 11. Selection Bias; 12. Vancomycin [therapeutic use]; | Provide MESH terms for the study
Antibiotic lock for the prevention of catheter‐related infection in neonates | You are a research assistant. Based on the question please provide appropriate answers |
1. *Antibiotic Prophylaxis; 2. Cerebrospinal Fluid Leak [complications]; 3. Cerebrospinal Fluid Rhinorrhea [complications]; 4. Meningitis, Bacterial [etiology, *prevention & control]; 5. Randomized Controlled Trials as Topic; 6. Skull Fracture, Basilar [*complications]; | Provide MESH terms for the study
Antibiotic prophylaxis for preventing meningitis in patients with basilar skull fractures | You are a research assistant. Based on the question please provide appropriate answers |
1. *Pneumocystis carinii; 2. AIDS‐Related Opportunistic Infections [*drug therapy]; 3. Adrenal Cortex Hormones [*therapeutic use]; 4. Chemotherapy, Adjuvant; 5. Hypoxia [etiology, therapy]; 6. Pneumonia, Pneumocystis [*drug therapy]; 7. Randomized Controlled Trials as Topic; 8. Respiration, Artificial; | Provide MESH terms for the study
Adjunctive corticosteroids for Pneumocystis jiroveci pneumonia in patients with HIV infection | You are a research assistant. Based on the question please provide appropriate answers |
1. Acetates [adverse effects, *therapeutic use]; 2. Bronchiolitis [*drug therapy]; 3. Cyclopropanes; 4. Length of Stay; 5. Leukotriene Antagonists [adverse effects, *therapeutic use]; 6. Quinolines [adverse effects, *therapeutic use]; 7. Randomized Controlled Trials as Topic; 8. Sulfides; | Provide MESH terms for the study
Leukotriene inhibitors for bronchiolitis in infants and young children | You are a research assistant. Based on the question please provide appropriate answers |
1. Acute Disease; 2. Amoxicillin [*therapeutic use]; 3. Amoxicillin‐Potassium Clavulanate Combination [*therapeutic use]; 4. Anti‐Bacterial Agents [*therapeutic use]; 5. Azithromycin [*therapeutic use]; 6. Bronchitis [*drug therapy]; 7. Drug Therapy, Combination; 8. Pneumonia [*drug therapy]; 9. Randomized Controlled Trials as Topic; 10. Respiratory Tract Infections [drug therapy]; 11. Treatment Failure; | Provide MESH terms for the study
Azithromycin for acute lower respiratory tract infections | You are a research assistant. Based on the question please provide appropriate answers |
1. *Infant Mortality; 2. Anti‐Infective Agents, Local [*therapeutic use]; 3. Bacterial Infections [mortality, *prevention & control]; 4. Chlorhexidine [*therapeutic use]; 5. Inflammation [prevention & control]; 6. Randomized Controlled Trials as Topic; 7. Skin [*microbiology]; 8. Umbilical Cord [*microbiology]; 9. Umbilicus; 10. Vagina [microbiology]; | Provide MESH terms for the study
Chlorhexidine skin or cord care for prevention of mortality and infections in neonates | You are a research assistant. Based on the question please provide appropriate answers |
1. Dehydration [etiology, *therapy]; 2. Disease Management; 3. Hemorrhagic Fever, Ebola [*complications]; 4. Hypodermoclysis; 5. Infusions, Intraosseous; 6. Infusions, Intravenous; 7. Infusions, Parenteral [*methods]; 8. Saphenous Vein; | Provide MESH terms for the study
Comparison of routes for achieving parenteral access with a focus on the management of patients with Ebola virus disease | You are a research assistant. Based on the question please provide appropriate answers |
1. Central Nervous System Parasitic Infections [*drug therapy]; 2. Eosinophilia [*drug therapy]; 3. Glucocorticoids [*therapeutic use]; 4. Meningitis [*drug therapy]; 5. Prednisolone [*therapeutic use]; 6. Randomized Controlled Trials as Topic; | Provide MESH terms for the study
Corticosteroids for parasitic eosinophilic meningitis | You are a research assistant. Based on the question please provide appropriate answers |
1. Microbiological Techniques; 2. Pregnancy Complications, Infectious [*blood, therapy]; 3. Pyelonephritis [*blood]; | Provide MESH terms for the study
Routine blood cultures in the management of pyelonephritis in pregnancy for improving outcomes | You are a research assistant. Based on the question please provide appropriate answers |
1. *Blood Donors; 2. Anti‐Infective Agents, Local [*administration & dosage]; 3. Bacteremia [*prevention & control]; 4. Blood Transfusion; 5. Disinfection [*methods]; 6. Ethanol [*administration & dosage]; 7. Skin [*microbiology]; | Provide MESH terms for the study
Skin preparation with alcohol versus alcohol followed by any antiseptic for preventing bacteraemia or contamination of blood for transfusion | You are a research assistant. Based on the question please provide appropriate answers |
1. Anti‐HIV Agents [*administration & dosage, adverse effects]; 2. Developing Countries; 3. HIV Infections [*drug therapy, virology]; 4. HIV‐1; 5. Randomized Controlled Trials as Topic; 6. Stavudine [*administration & dosage, adverse effects]; 7. Viral Load [drug effects]; | Provide MESH terms for the study
Low dose versus high dose stavudine for treating people with HIV infection | You are a research assistant. Based on the question please provide appropriate answers |
1. Anti‐Bacterial Agents [*therapeutic use]; 2. Bronchiolitis [diagnostic imaging, *drug therapy]; 3. Erythromycin [*therapeutic use]; 4. Haemophilus Infections [diagnostic imaging, *drug therapy]; 5. Macrolides [therapeutic use]; 6. Randomized Controlled Trials as Topic; 7. Tomography, X‐Ray Computed; | Provide MESH terms for the study
Macrolides for diffuse panbronchiolitis | You are a research assistant. Based on the question please provide appropriate answers |
1. Gestational Age; 2. Pneumococcal Infections [immunology, *prevention & control]; 3. Pneumococcal Vaccines [*administration & dosage]; 4. Randomized Controlled Trials as Topic; 5. Vaccination [*methods]; | Provide MESH terms for the study
Pneumococcal vaccination during pregnancy for preventing infant infection | You are a research assistant. Based on the question please provide appropriate answers |
1. Fasciitis, Necrotizing [*therapy]; 2. Hyperbaric Oxygenation [*methods]; | Provide MESH terms for the study
Adjunctive hyperbaric oxygen for necrotizing fasciitis | You are a research assistant. Based on the question please provide appropriate answers |
1. *Mycoplasma pneumoniae; 2. Amoxicillin‐Potassium Clavulanate Combination [therapeutic use]; 3. Anti‐Bacterial Agents [*therapeutic use]; 4. Azithromycin [therapeutic use]; 5. Bronchitis [*drug therapy, microbiology]; 6. Community‐Acquired Infections [drug therapy, microbiology]; 7. Erythromycin [therapeutic use]; 8. Pneumonia, Mycoplasma [*drug therapy]; 9. Randomized Controlled Trials as Topic; | Provide MESH terms for the study
Antibiotics for community‐acquired lower respiratory tract infections secondary to Mycoplasma pneumoniae in children | You are a research assistant. Based on the question please provide appropriate answers |
1. *Amnion; 2. Ampicillin [therapeutic use]; 3. Anti‐Bacterial Agents [*therapeutic use]; 4. Cefotetan [therapeutic use]; 5. Chorioamnionitis [*drug therapy]; 6. Clindamycin [therapeutic use]; 7. Delivery, Obstetric; 8. Drug Administration Schedule; 9. Endometritis [etiology]; 10. Fetal Diseases [etiology]; 11. Gentamicins [therapeutic use]; 12. Postpartum Period; 13. Sepsis [etiology]; 14. Sulbactam [therapeutic use]; | Provide MESH terms for the study
Antibiotic regimens for management of intra‐amniotic infection | You are a research assistant. Based on the question please provide appropriate answers |
1. Extracorporeal Membrane Oxygenation [statistics & numerical data]; 2. Meconium Aspiration Syndrome [*drug therapy, mortality]; 3. Pulmonary Surfactants [*therapeutic use]; 4. Randomized Controlled Trials as Topic; | Provide MESH terms for the study
Surfactant for meconium aspiration syndrome in term and late preterm infants | You are a research assistant. Based on the question please provide appropriate answers |
1. *Streptococcus agalactiae; 2. Administration, Intravaginal; 3. Anti‐Infective Agents, Local [*administration & dosage]; 4. Chlorhexidine [*administration & dosage]; 5. Labor, Obstetric; 6. Randomized Controlled Trials as Topic; 7. Streptococcal Infections [*prevention & control]; 8. Vaginal Creams, Foams, and Jellies [administration & dosage]; | Provide MESH terms for the study
Vaginal chlorhexidine during labour to prevent early‐onset neonatal group B streptococcal infection | You are a research assistant. Based on the question please provide appropriate answers |
1. Anti‐Bacterial Agents [*administration & dosage]; 2. Antibiotic Prophylaxis [*standards]; 3. Cesarean Section [*adverse effects]; 4. Drug Administration Schedule; 5. Endometritis [prevention & control]; 6. Injections, Intravenous; 7. Randomized Controlled Trials as Topic; 8. Surgical Wound Infection [*prevention & control]; 9. Urinary Tract Infections [prevention & control]; | Provide MESH terms for the study
Timing of intravenous prophylactic antibiotics for preventing postpartum infectious morbidity in women undergoing cesarean delivery | You are a research assistant. Based on the question please provide appropriate answers |
Subsets and Splits
No community queries yet
The top public SQL queries from the community will appear here once available.